![Markus Reich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Reich
Privat kapitalinvesterare på
Cross Equity Partners AG
Profil
Mr. Markus Reich is Managin Partner at Cross Equity Partners AG.
He was Partner in the Growth Capital Partnership and co-head of 3i Switzerland, which he helped establish in early 2000.
Before joining 3i he was a member of the Executive Board of the largest Swiss management consulting company, focusing on interim management, turnarounds and reorganisations, and mergers and acquisitions.
Markus specialises in growth capital investments and buyouts in Switzerland.
Key deals that he has been involved in include ECS (producer of specific inks and dyes), u-blox (provider of positioning technology), Arpida (development of anti-infective drugs), MIB AG (facility management) and Pilatus Flugzeugwerke AG (aircraft manufacturer).Markus is a board member of a world market leading conglomerate in cosmetic products/direct sales and a lecturer at top management and finance courses on private equity.
He is also a founding member of a Rotary Club in Switzerland.He studied Business Administration at the University Zurich and holds a Master of Business Administration (lic.
oec.) with majors in management, corporate finance and accounting.
Aktiva positioner av Markus Reich
| Företag | Position | Start |
|---|---|---|
Cross Equity Partners AG
 Cross Equity Partners AG Investment ManagersFinance Cross is an active manager which invests in middle-market companies located in Switzerland, Germany and Austria. The firm provides equity financing for growth capital requirements, buyout transactions and corporate spin-offs in niche market enterprises operating in the engineering, machinery and industrial products sectors. | Privat kapitalinvesterare | 2010-06-03 |
Tidigare kända positioner av Markus Reich
| Företag | Position | Slut |
|---|---|---|
3i Schweiz AG
 3i Schweiz AG Investment ManagersFinance 3i Schweiz is an active manager which aims to partner with established Swiss businesses with sustainable growth prospects, talented, entrepreneurial management teams, a leading position with clear differentiating factors and highly profitable growth potential. The firm has experience in a wide range of industries, with a particular focus on the healthcare, media, industrial products, engineering and services sectors. The Swiss team's typical growth capital investment ranges from CHF 15-200 million. They work in partnership with investee companies as minority shareholders, helping established Swiss businesses achieve organic growth, shareholder restructurings and acquisitions. For buyouts, 3i Schweiz aims to acquire majority holdings in established, mid-cap companies with a typical enterprise value of approximately CHF 70 million-1.5 billion. The firm participates in MBOs, spin-offs of non-core divisions from multinational companies or in supporting IPO preparations. | Direktör/Styrelseledamot | 2007-01-01 |
Micro-Macinazione SA
 Micro-Macinazione SA Pharmaceuticals: MajorHealth Technology Provides micronization technologies and services for the pharmaceutical and fine chemical industry | Direktör/Styrelseledamot | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
12
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
3i Schweiz AG
3i Schweiz AG Investment ManagersFinance 3i Schweiz is an active manager which aims to partner with established Swiss businesses with sustainable growth prospects, talented, entrepreneurial management teams, a leading position with clear differentiating factors and highly profitable growth potential. The firm has experience in a wide range of industries, with a particular focus on the healthcare, media, industrial products, engineering and services sectors. The Swiss team's typical growth capital investment ranges from CHF 15-200 million. They work in partnership with investee companies as minority shareholders, helping established Swiss businesses achieve organic growth, shareholder restructurings and acquisitions. For buyouts, 3i Schweiz aims to acquire majority holdings in established, mid-cap companies with a typical enterprise value of approximately CHF 70 million-1.5 billion. The firm participates in MBOs, spin-offs of non-core divisions from multinational companies or in supporting IPO preparations. | Finance |
Cross Equity Partners AG
Cross Equity Partners AG Investment ManagersFinance Cross is an active manager which invests in middle-market companies located in Switzerland, Germany and Austria. The firm provides equity financing for growth capital requirements, buyout transactions and corporate spin-offs in niche market enterprises operating in the engineering, machinery and industrial products sectors. | Finance |
Micro-Macinazione SA
Micro-Macinazione SA Pharmaceuticals: MajorHealth Technology Provides micronization technologies and services for the pharmaceutical and fine chemical industry | Health Technology |
